BioTech Investors in United States
588 investors · 429 with verified email
VCSift lists 588 BioTech investors in United States, 429 with a verified email address. They include 491 VC firms, 36 accelerators and 28 private equity investors. Profiles show firm, title, focus and, for subscribers, direct contact details.
BioTech
United States
588 investors
Other lists for United States
Fintech investors in United States (8,542)
PropTech investors in United States (2,082)
HealthTech investors in United States (1,779)
SaaS investors in United States (1,589)
EdTech investors in United States (735)
MarTech investors in United States (641)
Crypto/Web3 investors in United States (571)
AI/ML investors in United States (439)
Consumer investors in United States (396)
InsurTech investors in United States (389)
E-Commerce investors in United States (382)
CleanTech investors in United States (324)
Hardware investors in United States (163)
Marketplace investors in United States (81)
All investors in United States
BioTech investors by country and stage
BioTech investors in United Kingdom (71)
BioTech investors in Canada (45)
BioTech investors in Germany (42)
BioTech investors in Switzerland (38)
BioTech investors in France (28)
BioTech investors in India (28)
BioTech investors in Israel (24)
BioTech investors in Spain (22)
BioTech investors in Australia (22)
Seed BioTech investors (2,840)
Growth BioTech investors (1,900)
Pre-Seed BioTech investors (519)
Series A BioTech investors (292)
Series C BioTech investors (108)
All BioTech investors
Frequently asked questions about BioTech investors in United States
588 as of September 2026, 429 with a verified email address. They include 491 VC firms, 36 accelerators and 28 private equity investors.
Most investors on this list are individual angels rather than firm partners.
Yes. Essentials subscribers export up to 1,000 contacts a month as CSV; Pro subscribers have unlimited exports. Rows include name, firm, title, email, LinkedIn URL, stages, sectors and location.